Penumbra, Inc. to Participate in CEO Discussion with Bank of America

ALAMEDA, Calif., Dec. 4, 2020 — Penumbra, Inc. (NYSE: PEN) today announced that its chief executive officer is scheduled to participate in a discussion with Bank of America on Tuesday, December 8, 2020.

Event: CEO Discussion with Bank of America
Date: Tuesday, December 8, 2020
Time: 8:30am ET / 5:30am PT

An audio webcast of the discussion will be available by visiting the investors’ section of the company’s website at The audio webcast will be available on the company’s website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit

Investor Relations
Penumbra, Inc.
[email protected]

Cision View original content to download multimedia:

SOURCE Penumbra, Inc.


Contact us to learn more about our products and company